Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

The features of breast lymphoma on MRI.

Liu K, Xie P, Peng W, Zhou Z.

Br J Radiol. 2013 Nov;86(1031):20130220. doi: 10.1259/bjr.20130220. Epub 2013 Sep 12.

2.

Magnetic resonance imaging of primary breast lymphoma.

Rizzo S, Preda L, Villa G, Brambilla S, Pruneri G, Alietti A, Cassano E, Martinelli G, Bellomi M.

Radiol Med. 2009 Sep;114(6):915-24. doi: 10.1007/s11547-009-0420-8. Epub 2009 Jun 26. English, Italian.

PMID:
19562266
3.

MRI features of breast lymphoma: preliminary experience in seven cases.

Wang L, Wang D, Chai W, Fei X, Luo R, Li X.

Diagn Interv Radiol. 2015 Nov-Dec;21(6):441-7. doi: 10.5152/dir.2015.14534.

4.

Breast cancer in very young women (<30 years): Correlation of imaging features with clinicopathological features and immunohistochemical subtypes.

An YY, Kim SH, Kang BJ, Park CS, Jung NY, Kim JY.

Eur J Radiol. 2015 Oct;84(10):1894-902. doi: 10.1016/j.ejrad.2015.07.002. Epub 2015 Jul 9.

PMID:
26198117
5.

MR features to suggest microinvasive ductal carcinoma of the breast: can it be differentiated from pure DCIS?

Hahn SY, Han BK, Ko EY, Shin JH, Hwang JY, Nam M.

Acta Radiol. 2013 Sep;54(7):742-8. doi: 10.1177/0284185113484640. Epub 2013 Apr 30.

PMID:
23588154
6.

Development, standardization, and testing of a lexicon for reporting contrast-enhanced breast magnetic resonance imaging studies.

Ikeda DM, Hylton NM, Kinkel K, Hochman MG, Kuhl CK, Kaiser WA, Weinreb JC, Smazal SF, Degani H, Viehweg P, Barclay J, Schnall MD.

J Magn Reson Imaging. 2001 Jun;13(6):889-95.

PMID:
11382949
7.

Use of BI-RADS-MRI descriptors for differentiation between mucinous carcinoma and fibroadenoma.

Igarashi T, Ashida H, Morikawa K, Motohashi K, Fukuda K.

Eur J Radiol. 2016 Jun;85(6):1092-8. doi: 10.1016/j.ejrad.2016.03.012. Epub 2016 Mar 17.

PMID:
27161057
8.

[Mammographic, magnetic resonance imaging and clinicopathological characteristics of primary breast lymphoma].

Zhang SJ, He MZ, Zheng LL, Gu YJ, Peng WJ.

Zhonghua Zhong Liu Za Zhi. 2016 Jul;38(7):521-5. doi: 10.3760/cma.j.issn.0253-3766.2016.07.008. Chinese.

PMID:
27531266
9.

Comparative analysis of imaging and pathology features of mucinous carcinoma of the breast.

Zhang L, Jia N, Han L, Yang L, Xu W, Chen W.

Clin Breast Cancer. 2015 Apr;15(2):e147-54. doi: 10.1016/j.clbc.2014.11.005. Epub 2014 Nov 18.

PMID:
25523373
10.

Medullary carcinoma of the breast: MRI findings.

Jeong SJ, Lim HS, Lee JS, Park MH, Yoon JH, Park JG, Kang HK.

AJR Am J Roentgenol. 2012 May;198(5):W482-7. doi: 10.2214/AJR.11.6944.

PMID:
22528930
11.

Characterization of the enhancing lesions on dynamic contrast enhanced magnetic resonance imaging in patients with interstitial mammoplasty.

Kim TY, Kim SH, Kang BJ, Kim HS, Cha ES, Kim JY, Song BJ.

Eur J Radiol. 2013 Dec;82(12):2205-11. doi: 10.1016/j.ejrad.2013.09.008. Epub 2013 Sep 23.

PMID:
24103354
12.

Selection of diagnostic features on breast MRI to differentiate between malignant and benign lesions using computer-aided diagnosis: differences in lesions presenting as mass and non-mass-like enhancement.

Newell D, Nie K, Chen JH, Hsu CC, Yu HJ, Nalcioglu O, Su MY.

Eur Radiol. 2010 Apr;20(4):771-81. doi: 10.1007/s00330-009-1616-y. Epub 2009 Sep 30.

13.

MR imaging of malignant primary breast lymphoma: including diffusion-weighted imaging, histologic features, and a literature review.

Matsubayashi RN, Inoue Y, Okamura S, Momosaki S, Nakazono T, Muranaka T.

Jpn J Radiol. 2013 Oct;31(10):668-76. doi: 10.1007/s11604-013-0232-6. Epub 2013 Jul 12. Review.

PMID:
23846235
14.

BI-RADS lesion characteristics predict likelihood of malignancy in breast MRI for masses but not for nonmasslike enhancement.

Gutierrez RL, DeMartini WB, Eby PR, Kurland BF, Peacock S, Lehman CD.

AJR Am J Roentgenol. 2009 Oct;193(4):994-1000. doi: 10.2214/AJR.08.1983.

PMID:
19770321
15.

Rim-enhancing breast masses with smooth or spiculated margins on magnetic resonance imaging: histopathology and clinical significance.

Uematsu T, Kasami M, Nicholson BT.

Jpn J Radiol. 2011 Nov;29(9):609-14. doi: 10.1007/s11604-011-0612-8. Epub 2011 Sep 29. Review.

PMID:
21956365
16.

Invasive lobular carcinoma: spectrum of enhancement and morphology on magnetic resonance imaging.

Yeh ED, Slanetz PJ, Edmister WB, Talele A, Monticciolo D, Kopans DB.

Breast J. 2003 Jan-Feb;9(1):13-8.

PMID:
12558665
17.

Enhanced mass on contrast-enhanced breast MR imaging: Lesion characterization using combination of dynamic contrast-enhanced and diffusion-weighted MR images.

Yabuuchi H, Matsuo Y, Okafuji T, Kamitani T, Soeda H, Setoguchi T, Sakai S, Hatakenaka M, Kubo M, Sadanaga N, Yamamoto H, Honda H.

J Magn Reson Imaging. 2008 Nov;28(5):1157-65. doi: 10.1002/jmri.21570.

PMID:
18972357
18.

Primary adrenal lymphoma: radiological; pathological, clinical correlation.

Zhou L, Peng W, Wang C, Liu X, Shen Y, Zhou K.

Eur J Radiol. 2012 Mar;81(3):401-5. doi: 10.1016/j.ejrad.2010.11.026. Epub 2010 Dec 13.

PMID:
21146945
19.

BI-RADS MRI enhancement characteristics of ductal carcinoma in situ.

Rosen EL, Smith-Foley SA, DeMartini WB, Eby PR, Peacock S, Lehman CD.

Breast J. 2007 Nov-Dec;13(6):545-50.

PMID:
17983393
20.

Comparison of gadoteric acid and gadobutrol for detection as well as morphologic and dynamic characterization of lesions on breast dynamic contrast-enhanced magnetic resonance imaging.

Renz DM, Durmus T, Böttcher J, Taupitz M, Diekmann F, Huppertz A, Pfeil A, Maurer MH, Streitparth F, Bick U, Hamm B, Fallenberg EM.

Invest Radiol. 2014 Jul;49(7):474-84. doi: 10.1097/RLI.0000000000000039.

PMID:
24637587

Supplemental Content

Support Center